V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20159523 | 20061279 | 1.52 | 62 | Neo-adjuvant (N) | 2016-07-02 | 2016-08-05 | ECX | N | N | ECX | 101088291 |
| 20159525 | 20061280 | 1.74 | 79 | Neo-adjuvant (N) | 2016-12-19 | 2016-12-27 | ECX | N | N | ECX | 101710518 |
| 20159526 | 20061281 | 1.63 | 65.7 | Adjuvant (A) | 2017-11-15 | 2017-11-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101030120 |
| 20159531 | 20061282 | 1.74 | 80.3 | Neo-adjuvant (N) | 2019-03-12 | 2019-03-21 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100590963 |
| 20159532 | 20061283 | 1.77 | 92 | Adjuvant (A) | 2016-09-10 | 2016-09-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100414877 |
| 20159534 | 20061284 | 1.7 | 58.2 | Palliative (P) | 2017-01-29 | 2017-01-29 | ECX | 2 | N | ECX | 100080355 |
| 20159536 | 20061285 | 1.76 | 51.7 | Neo-adjuvant (N) | 2018-08-10 | 2018-09-01 | Gemcitabine + Capecitabine | 01 | N | CAPECITABINE + GEMCITABINE | 101002423 |
| 20159539 | 20061286 | 1.65 | 65.5 | Adjuvant (A) | null | 2018-09-19 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100120116 |
| 20159541 | 20061287 | 1.62 | 55.9 | Curative (C) | 2016-02-02 | 2016-02-29 | ECX | N | N | ECX | 101359958 |
| 20159542 | 20061288 | 1.55 | 76.9 | Palliative (P) | 2018-07-19 | 2018-08-02 | ECX | N | N | ECX | 101327832 |
| 20159543 | 20061289 | 1.77 | 75.6 | Adjuvant (A) | 2018-01-04 | 2018-01-27 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100084751 |
| 20159545 | 20061290 | 1.82 | 64.8 | Adjuvant (A) | 2018-11-04 | 2018-11-25 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 101392370 |
| 20159546 | 20061291 | 1.49 | 104 | Palliative (P) | 2016-07-25 | 2016-08-10 | ECX | N | N | ECX | 101019318 |
| 20159547 | 20061292 | 1.62 | 71.4 | null | 2018-01-29 | 2018-01-30 | CAPECITABINE + GEMCITABINE | N | N | ECX | 100701927 |
| 20159548 | 20061293 | null | null | Adjuvant (A) | 2017-12-10 | 2017-12-10 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 101377944 |
| 20159551 | 20061294 | 1.7 | 85.8 | Neo-adjuvant (N) | 2019-11-02 | 2019-11-21 | ECX | N | N | ECX | 100720174 |
| 20159553 | 20061295 | 1.74 | 71.7 | Neo-adjuvant (N) | 2018-06-03 | 2018-06-03 | ECX | N | N | ECX | 101485798 |
| 20159555 | 20061296 | 1.7 | 96.8 | Neo-adjuvant (N) | 2018-08-28 | 2018-10-03 | Gemcitabine + Capecitabine | N | N | ECX | 101137703 |
| 20159561 | 20061297 | 1.73 | 78.2 | Neo-adjuvant (N) | 2019-08-24 | 2019-08-27 | ECX | N | N | ECX | 101864090 |
| 20159562 | 20061298 | 1.68 | 93.4 | Curative (C) | null | 2017-04-02 | Gemcitabine + Capecitabine | N | Y | CAPECITABINE + GEMCITABINE | 101575729 |
| 20159566 | 20061299 | 1.68 | 48.9 | Palliative (P) | 2019-04-23 | 2019-05-08 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100941442 |
| 20159567 | 20061300 | 1.69 | 92.1 | Neo-adjuvant (N) | 2018-05-02 | 2018-05-16 | ECX | N | null | ECX | 101646831 |
| 20159569 | 20061301 | 1.6 | 64 | Palliative (P) | 2017-07-15 | 2017-07-29 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100657853 |
| 20159570 | 20061302 | 1.75 | 84 | null | 2019-11-11 | 2019-11-15 | ECX | N | N | ECX | 100376508 |
| 20159571 | 20061303 | 1.79 | 85.7 | Neo-adjuvant (N) | 2017-07-31 | 2017-07-31 | ECX | N | N | ECX | 101108881 |
| 20159572 | 20061304 | 1.55 | 74.8 | Palliative (P) | 2018-08-01 | 2018-08-11 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100445858 |
| 20159573 | 20061305 | 1.47 | 54.85 | Palliative (P) | 2016-05-02 | 2016-05-04 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 101340619 |
| 20159574 | 20061306 | 1.54 | 57 | Palliative (P) | 2016-12-30 | 2017-01-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101755824 |
| 20159575 | 20061307 | 1.62 | 75.7 | Curative (C) | 2019-12-05 | 2019-12-12 | ECX | N | N | ECX | 100005671 |
| 20159577 | 20061308 | 1.83 | 73.2 | Palliative (P) | 2017-03-29 | 2017-04-03 | ECX | N | null | ECX | 101719672 |
| 20159578 | 20061309 | 1.54 | 75 | Neo-adjuvant (N) | 2018-12-21 | 2018-12-22 | ECX | 2 | N | ECX | 100418434 |
| 20159579 | 20061310 | 0.67 | 72.6 | Palliative (P) | 2019-01-27 | 2019-02-08 | ECX | N | N | ECX | 100066747 |
| 20159580 | 20061311 | 1.8 | 92.55 | Neo-adjuvant (N) | 2018-04-10 | 2018-04-19 | ECX | N | N | ECX | 100212850 |
| 20159581 | 20061312 | 1.62 | 64.3 | Palliative (P) | 2018-10-04 | 2018-10-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101257765 |
| 20159583 | 20061313 | 1.74 | 84.9 | Neo-adjuvant (N) | 2017-08-28 | 2017-09-08 | ECX | 02 | N | ECX | 101399997 |
| 20159585 | 20061314 | 1.74 | 49.7 | Palliative (P) | 2018-08-30 | 2018-09-09 | ECX | 02 | N | ECX | 100403130 |
| 20159587 | 20061315 | 1.71 | 78 | Neo-adjuvant (N) | 2018-09-23 | 2018-09-28 | ECX | null | N | CAPECITABINE + GEMCITABINE | 100108491 |
| 20159588 | 20061316 | 1.78 | 93 | Adjuvant (A) | 2019-01-09 | 2019-02-01 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 100196866 |
| 20159589 | 20061317 | 1.64 | 90 | Adjuvant (A) | 2017-08-18 | 2017-08-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101308748 |
| 20159592 | 20061318 | 1.66 | 99.8 | Neo-adjuvant (N) | 2020-01-08 | 2020-01-15 | ECX | N | N | ECX | 100531183 |
| 20159593 | 20061319 | 1.69 | 89.3 | Palliative (P) | 2016-03-08 | 2016-03-08 | ECX | 02 | N | ECX | 101707834 |
| 20159596 | 20061320 | 1.6 | 46 | Neo-adjuvant (N) | 2018-05-05 | 2018-05-18 | ECX | N | N | ECX | 100357026 |
| 20159599 | 20061321 | 1.56 | 96.6 | Neo-adjuvant (N) | 2016-06-26 | 2016-07-06 | ECX | N | N | ECX | 100454132 |
| 20159600 | 20061322 | 1.8 | 73.45 | Palliative (P) | 2019-06-23 | 2019-06-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101593149 |
| 20159601 | 20061323 | null | null | null | 2016-10-15 | 2016-10-16 | ECX | null | N | CAPECITABINE + GEMCITABINE | 101678250 |
| 20159602 | 20061324 | 1.69 | 76.4 | Adjuvant (A) | 2018-01-22 | 2018-02-06 | ECX | 02 | N | ECX | 100430625 |
| 20159603 | 20061325 | 1.7 | 63 | Adjuvant (A) | 2019-03-02 | 2019-03-09 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100489291 |
| 20159604 | 20061326 | 1.78 | 61 | Neo-adjuvant (N) | 2016-12-21 | 2016-12-22 | ECX | 02 | N | ECX | 100313104 |
| 20159606 | 20061327 | 1.74 | 71 | null | 2016-09-07 | 2016-09-20 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101430172 |
| 20159607 | 20061328 | 1.73 | 96.3 | Palliative (P) | 2018-11-04 | 2019-01-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101257164 |